Stay updated on MAPP2 MDMA Therapy Clinical Trial
Sign up to get notified when there's something new on the MAPP2 MDMA Therapy Clinical Trial page.

Latest updates to the MAPP2 MDMA Therapy Clinical Trial page
- Check4 days agoChange DetectedLocations section updated to include California, Colorado, Connecticut, Louisiana, Massachusetts, New York, South Carolina, and Wisconsin, with the page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.9%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedAdded a note in Publications: 'These publications are automatically filled in from PubMed, a public database of scientific and medical articles, and may or may not be about the study.'; Updated the revision label from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check40 days agoChange DetectedThe government funding/systems status notice is removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check54 days agoChange DetectedThe updated page mainly shows minor layout and metadata updates, with core study details such as eligibility criteria, endpoints, and locations remaining unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check83 days agoChange Detected- Added a prominent notice about government funding lapse and current operating status, plus a link to cc.nih.gov and opm.gov. - Updated version to v3.2.0. - Removed explicit reference to v3.1.0.SummaryDifference3%

- Check90 days agoChange DetectedPage now indicates a new version (v3.1.0) and removes several drug-related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) indicating content consolidation and reorganization.SummaryDifference0.4%

Stay in the know with updates to MAPP2 MDMA Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MAPP2 MDMA Therapy Clinical Trial page.